Kiniksa Pharmaceuticals International Plc. Goodwill

Kiniksa Pharmaceuticals International Plc. (KNSA) currently reports a goodwill of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Kiniksa Pharmaceuticals International Plc.'s goodwill history and peer comparisons.

Kiniksa Pharmaceuticals International Plc.'s goodwill changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kiniksa Pharmaceuticals International Plc. reported $0 in goodwill as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kiniksa Pharmaceuticals International Plc., and consider following KNSA for alerts when major investors trade the stock.

Kiniksa Pharmaceuticals International Plc. is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KNSA with unrelated industries.